Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study.
Aug 2007 - Oncol. Rep.; 18(3):1021-335X [PMID:17671717]
[Wei YC] [Sticca RP] [Li J] [Holmes LM] [Burgin KE] [Jakubchak S] [Bouton-Verville H] [Williamson J] [Meyer K] [Evans L] [Martin J] [Stephenson JJ] [Trocha S] [Smith S] [Wagner TE]

Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
Jun 2006 - J. Immunol.; 176(10):0022-1767 [PMID:16670315]
[Li W] [Krishnadas DK] [Li J] [Tyrrell DL] [Agrawal B]

[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]
Mar 2006 - Zhonghua Xue Ye Xue Za Zhi; 26(10):0253-2727 [PMID:16532967]
[Zhang M] [Yin XR] [Luo YY] [Lin X] [Wang MC] [He PC] [Li J] [Guo GL] [Cai RH] [Liu YL]

Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.
Feb 2006 - Int. J. Oncol.; 28(3):1019-6439 [PMID:16465362]
[Wei Y] [Sticca RP] [Holmes LM] [Burgin KE] [Li J] [Williamson J] [Evans L] [Smith SJ] [Stephenson JJ] [Wagner TE]

[Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene]
Aug 2004 - Ai Zheng; 23(8):1000-467X [PMID:15301713]
[Mi ZQ] [Jin NY] [Sun YC] [Li X] [Lian H] [Li J] [Guan GF]